Skip to main content
OpenTrials
Completed

NCT Number: NCT00142558

A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)

A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Gout

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males or females at least 18 years of age who have acute gout.

Treatment and study plan

MK0663; etoricoxib / Duration of Treatment: 5 Days

Drug

Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days

Drug

Primary outcomes

  1. Patient assessment of pain (0- to 4- Likert scale)

Secondary outcomes

  1. Patient Global Assessment of Response to Therapy (0- to 4- point scale)

  2. Investigator Global Assessment of Response to Therapy (0- to 4- point scale)

  3. Tenderness of the study joint (0- to 3-point scale)

  4. Swelling of the study joint (0- to 3-point scale)

Sponsors and collaborators

Lead sponsor

Organon and Co

Industry

Registry information

Official study title

A Randomized, Double-Blind, Active-Comparator-Controlled 5-Day Trial of the Effect of Etoricoxib 120 mg Versus Indomethacin 150 mg in the Treatment of Acute Gout

Important dates

Study start
2005
Primary completion
2005
Study completion
2005
First posted
Sep 2, 2005
Registry last updated
Aug 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.